Get the Stockscreener App
2.46
7.52%
-0.20
Marker Therapeutics Inc Stock (MRKR) Forecast
The Marker Therapeutics Inc (MRKR) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $19.25, representing a +682.33% increase from the current price of $2.46. The highest analyst price target is $19.18, and the lowest is $19.31.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month MRKR Price Target
Average 23.54
(+857.09% Upside)
Is Marker Therapeutics Inc (MRKR) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 35.15 | Neutral |
| STOCH(9,6) | 11.85 | Buy |
| STOCHRSI(14) | 6.672 | Buy |
| MACD(12,26) | -0.2844 | Sell |
| ADX(14) | 24.62 | Neutral |
| William %R | -100.00 | Buy |
| CCI(14) | -55.77 | Neutral |
Buy: 3
Sell: 1
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.822
Sell
|
2.808
Sell
|
| MA20 |
3.1535
Sell
|
3.0609
Sell
|
| MA50 |
3.446
Sell
|
3.3283
Sell
|
| MA100 |
3.3289
Sell
|
3.4871
Sell
|
| MA200 |
3.8497
Sell
|
3.6788
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, MRKR could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 11 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on MRKR, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 35.15 indicates that MRKR is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 11.85 indicates that MRKR is oversold. This indicates that MRKR price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 6.672 indicates that MRKR is oversold. This suggests that MRKR price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 24.62 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -55.77 indicates that MRKR is still oversold but not to an extreme extent.
Long-term MRKR price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Marker Therapeutics Inc financial reports and earnings history, Marker Therapeutics Inc (MRKR) stock could reach $53.04 by 2030, $45.07 by 2040 and $131.23 by 2050. See the projected annual prices until 2050 of the Marker Therapeutics Inc stock below:
- Marker Therapeutics Inc (MRKR) is expected to reach an average price of $14.78 in 2035, with a high prediction of $16.24 and a low estimate of $14.97. This indicates an $500.95% rise from the last recorded price of $2.46.
- Marker Therapeutics Inc (MRKR) stock is projected to chart a bullish course in 2040, with an average price target of $43.58, representing an $1,672% surge from its current level. The forecast ranges from a conservative $43.66 to a sky-high $45.07.
- Our analysts predict Marker Therapeutics Inc (MRKR) to jump 3,124% by 2045, soaring from $79.60 to an average price of $79.30, potentially reaching $79.62. While $79.60 is the low estimate, the potential upside is significant.
- Marker Therapeutics Inc (MRKR) stock is expected to climb by 2050, reaching an average of $128.12, a $5,108% jump from its current level. However, a wide range of estimates exists, with high and low targets of $131.23 and $128.50, respectively, highlighting the market's uncertainty.
Marker Therapeutics Inc Stock (MRKR) Year by Year Forecast
Marker Therapeutics Inc Stock (MRKR) Price Forecast for 2025
Marker Therapeutics Inc Stock (MRKR) is expected to reach an average price of $23.54 in 2025, with a high prediction of $27.78 and a low estimate of $19.31. This indicates an +857.09% rise from the last recorded price of $2.46.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| February, 2025 | $22.55 | $19.31 | $19.18 | +816.77% |
| March, 2025 | $23.04 | $21.20 | $19.62 | +836.76% |
| April, 2025 | $27.86 | $23.97 | $27.46 | +1,032% |
| May, 2025 | $24.95 | $25.75 | $27.78 | +914.25% |
| June, 2025 | $22.34 | $22.40 | $20.22 | +808.22% |
| July, 2025 | $23.96 | $22.27 | $22.06 | +873.86% |
| August, 2025 | $24.75 | $23.83 | $23.30 | +906.04% |
| September, 2025 | $21.74 | $23.34 | $24.17 | +783.75% |
| October, 2025 | $26.15 | $24.96 | $24.41 | +963.20% |
| November, 2025 | $26.55 | $26.55 | $25.55 | +979.13% |
| December, 2025 | $27.06 | $25.04 | $26.07 | +1,000% |
Marker Therapeutics Inc Stock (MRKR) Price Forecast for 2026
The predicted value for Marker Therapeutics Inc (MRKR) in 2026 is set at an average of $14.27. Estimates vary from a peak of $25.78 to a trough of $2.7633, indicating an +480.23% surge from the present price of $2.46.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $23.05 | $24.75 | $25.78 | +837.11% |
| February, 2026 | $24.14 | $22.89 | $22.34 | +881.48% |
| March, 2026 | $17.84 | $20.94 | $23.27 | +625.05% |
| April, 2026 | $9.2508 | $10.85 | $17.58 | +276.05% |
| May, 2026 | $12.74 | $14.47 | $11.12 | +417.99% |
| June, 2026 | $14.93 | $14.27 | $13.33 | +507.08% |
| July, 2026 | $12.95 | $12.10 | $13.56 | +426.37% |
| August, 2026 | $1.1404 | $4.6404 | $6.3916 | -53.64% |
| September, 2026 | $7.155 | $2.7633 | $5.0321 | +190.85% |
| October, 2026 | $12.35 | $11.82 | $11.25 | +401.90% |
| November, 2026 | $12.54 | $13.44 | $13.29 | +409.69% |
| December, 2026 | $14.55 | $12.76 | $13.35 | +491.58% |
Marker Therapeutics Inc Stock (MRKR) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Marker Therapeutics Inc (MRKR) is $18.85, with a high forecast of $23.13 and a low forecast of $14.58. This indicates an +666.34% increase from the last price of $2.46.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $16.34 | $14.58 | $14.54 | +564.42% |
| February, 2027 | $17.04 | $15.99 | $15.64 | +592.53% |
| March, 2027 | $18.95 | $17.86 | $18.15 | +670.36% |
| April, 2027 | $20.36 | $19.17 | $19.69 | +727.63% |
| May, 2027 | $21.80 | $22.23 | $21.69 | +786.35% |
| June, 2027 | $22.83 | $22.02 | $23.13 | +828.08% |
| July, 2027 | $21.74 | $21.74 | $21.87 | +783.76% |
| August, 2027 | $21.93 | $21.62 | $21.34 | +791.55% |
| September, 2027 | $21.55 | $21.61 | $21.48 | +775.89% |
| October, 2027 | $21.17 | $21.34 | $20.97 | +760.51% |
| November, 2027 | $19.48 | $19.88 | $20.56 | +691.88% |
| December, 2027 | $18.31 | $18.40 | $19.15 | +644.26% |
Marker Therapeutics Inc Stock (MRKR) Price Forecast for 2028
In 2028, Marker Therapeutics Inc (MRKR) is projected to reach an average price of $14.29, with a high projection of $18.44 and a low estimate of $10.14. This indicates an +481.04% rise from the last price of $2.46.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $18.49 | $18.63 | $18.44 | +651.65% |
| February, 2028 | $17.14 | $17.03 | $16.85 | +596.75% |
| March, 2028 | $15.51 | $15.60 | $16.54 | +530.32% |
| April, 2028 | $16.02 | $15.97 | $15.48 | +551.32% |
| May, 2028 | $15.75 | $15.75 | $15.76 | +540.08% |
| June, 2028 | $14.34 | $14.63 | $15.44 | +482.96% |
| July, 2028 | $14.42 | $14.59 | $14.13 | +486.28% |
| August, 2028 | $14.19 | $14.21 | $14.23 | +476.71% |
| September, 2028 | $14.49 | $14.04 | $14.54 | +488.97% |
| October, 2028 | $13.19 | $13.73 | $13.96 | +436.19% |
| November, 2028 | $11.90 | $12.17 | $12.90 | +383.94% |
| December, 2028 | $9.9366 | $10.14 | $11.02 | +303.93% |
Marker Therapeutics Inc Stock (MRKR) Price Forecast for 2029
The 2029 price forecast for Marker Therapeutics Inc Stock (MRKR) is $25.51 on average, with a high prediction of $50.98 and a low estimate of $0.0445. This represents an +937.08% increase from the previous price of $2.46.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $7.1012 | $6.0243 | $8.4595 | +188.67% |
| February, 2029 | $5.7929 | $5.9329 | $6.3371 | +135.48% |
| March, 2029 | $5.3746 | $5.6046 | $5.2707 | +118.48% |
| April, 2029 | $6.7163 | $5.6975 | $6.1023 | +173.02% |
| May, 2029 | $6.4159 | $6.4908 | $6.745 | +160.81% |
| June, 2029 | $5.6725 | $5.7425 | $6.0332 | +130.59% |
| July, 2029 | $2.2242 | $3.8842 | $4.9305 | -9.58% |
| August, 2029 | $2.1988 | $2.7374 | $2.303 | -10.62% |
| September, 2029 | $2.1905 | $2.1616 | $1.9692 | -10.96% |
| October, 2029 | $0.3351 | $0.9933 | $2.0363 | -86.38% |
| November, 2029 | $0.3968 | $0.4169 | $0.2061 | -83.87% |
| December, 2029 | $51.78 | $0.0445 | $50.98 | +2,005% |
Marker Therapeutics Inc Stock (MRKR) Price Forecast for 2030
Marker Therapeutics Inc Stock (MRKR) is expected to reach an average price of $51.56 in 2030, with a high forecast of $74.53 and a low forecast of $28.59. This signifies an +1,996% surge from the last price of $2.46.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $47.31 | $55.07 | $53.04 | +1,823% |
| February, 2030 | $20.69 | $28.59 | $29.66 | +741.16% |
| March, 2030 | $64.58 | $46.74 | $60.55 | +2,525% |
| April, 2030 | $54.06 | $56.51 | $58.12 | +2,098% |
| May, 2030 | $52.89 | $48.58 | $51.29 | +2,050% |
| June, 2030 | $61.07 | $57.63 | $59.07 | +2,383% |
| July, 2030 | $72.40 | $62.91 | $71.00 | +2,843% |
| August, 2030 | $69.68 | $69.64 | $67.58 | +2,733% |
| September, 2030 | $68.47 | $69.73 | $69.12 | +2,683% |
| October, 2030 | $68.90 | $68.11 | $66.79 | +2,701% |
| November, 2030 | $78.48 | $71.53 | $71.08 | +3,090% |
| December, 2030 | $75.86 | $75.62 | $74.53 | +2,984% |
0.65%
4.62%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):